Fw: Guidance on use of Surplus Vaccines as GPs complete Over 70s Programme

GM
Gavin Maguire
Fri, Apr 2, 2021 12:06 PM

FYI

See below regarding use of excess vaccines


From: Irish Medical Organisation imo@imo.ie
Sent: 02 April 2021 12:34
To: Gavin Maguire gavin.maguire@centrichealth.ie
Subject: Guidance on use of Surplus Vaccines as GPs complete Over 70s Programme

‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Web Versionhttp://imo.newsweaver.com/memberadvisory/1v12ckf67spfyod79xdkvj?email=true&lang=en&a=11&p=59086832 | Unsubscribehttp://imo.newsweaver.com/memberadvisory/unsubscribe/unsubscribe.html?s=fyod79xdkvj&m=001xsh91n4v9o8qsfjq2uu&email=true&lang=en
Please add imo@imo.iemailto:imo@imo.ie to your address book to ensure that our emails reach your inbox.
[http://imo.newsweaver.com/v2files/shard1/45325/96/65f8a053f90976a4347f6d.jpg]

Dear Member,

In line with the age cohorts in the Over 70s Programme, GPs will, over the next number of weeks, be completing Dose 1 Clinics to those patients in the 70-74 cohort.  In circumstances where you have surplus doses at the end of those clinics, GPs should use such surplus vaccines in the following manner so as to ensure no vaccines are wasted.

  • In order to honour the intention of the NIAC vaccination recommendations that those at highest risk of severe disease and death be vaccinated first, it is recommended that remaining doses of vaccine be given to people in allocation group 4 (that is those people with medical conditions that places them at very high risk of severe disease). In so far as possible, priority within this group should be given to those aged 65 to 69 given the importance of age as a risk factor for severe disease.

  • In the event that patients from allocation group 4 are not available for vaccination for any reason, vaccine should be administered to patients in the next allocation groups for vaccination. As it is planned that allocation groups 5 and 6 will be vaccinated in mass vaccination centres and allocation group 7 will be vaccinated in General Practice, it is pragmatic for GPs to vaccinate people from their allocation group 7 list if no one from allocation group 4 is available for vaccination within the time frame for use of the vaccine.

  • You will be given sufficient vaccine to administer 2nd Doses to those on your contingency list as above

Allocation group 3 is those aged 70 years and older

Allocation group 4 is those with medical conditions that place them at very high risk of severe disease in the 16-69 age group

Allocation group 5 is those with medical conditions that place them at high risk of severe disease in the 65-69 age group

Allocation group 6 is all other people in the 65-69 age group

Allocation group 7 is people with medical conditions that place them at high risk of severe disease in the 16-64 age group

Please note further guidance will issue in respect of the use of surplus vaccines on the final (Dose 2) clinics as the MRNA programme in General Practice closes out.

Yours sincerely,

IMO Team

This email was sent to gavin.maguire@centrichealth.iemailto:gavin.maguire@centrichealth.ie from imo@imo.ie
Unsubscribehttp://imo.newsweaver.com/memberadvisory/unsubscribe/unsubscribe.html?s=fyod79xdkvj&m=001xsh91n4v9o8qsfjq2uu&email=true&lang=en | Receive in Plain Texthttp://imo.newsweaver.com/memberadvisory/subscriber/switchFormat.html?subscriberId=fyod79xdkvj&mailingRecordId=001xsh91n4v9o8qsfjq2uu&to=TEXT&email=true&lang=en | Report Misusehttp://imo.newsweaver.com/memberadvisory/1v12ckf67spfyod79xdkvj/abuse.html

This e-mail and any attachments including voice attachments may contain confidential, personal, sensitive, proprietary or legally privileged information. Anyone who is not the intended recipient should not use or open the document. Any information or voice recording used within this document or e-mail should not be forwarded to any other legal person or organisation or posted on any social media platform as to do so would be in breach of privacy and data protection legislation. If you have erroneously received this email or document, please delete immediately and notify the sender. If you have received this e-mail or documentation where there is a precise reason to forward to a third party, all rules regarding privacy and data protection should be followed. You will be liable for a third party breach.The recipients acknowledge that Centric Health or associated companies are unable to exercise control to ensure or guarantee the integrity of/over the contents of the information contained in e-mail transmission and further acknowledge that any views expressed in this message are those of the individual sender and no binding nature of the message shall be implied or assumed unless the sender does so expressly with due authority of Centric Health.

FYI See below regarding use of excess vaccines ________________________________ From: Irish Medical Organisation <imo@imo.ie> Sent: 02 April 2021 12:34 To: Gavin Maguire <gavin.maguire@centrichealth.ie> Subject: Guidance on use of Surplus Vaccines as GPs complete Over 70s Programme ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ Web Version<http://imo.newsweaver.com/memberadvisory/1v12ckf67spfyod79xdkvj?email=true&lang=en&a=11&p=59086832> | Unsubscribe<http://imo.newsweaver.com/memberadvisory/unsubscribe/unsubscribe.html?s=fyod79xdkvj&m=001xsh91n4v9o8qsfjq2uu&email=true&lang=en> Please add imo@imo.ie<mailto:imo@imo.ie> to your address book to ensure that our emails reach your inbox. [http://imo.newsweaver.com/v2files/shard1/45325/96/65f8a053f90976a4347f6d.jpg] Dear Member, In line with the age cohorts in the Over 70s Programme, GPs will, over the next number of weeks, be completing Dose 1 Clinics to those patients in the 70-74 cohort. In circumstances where you have surplus doses at the end of those clinics, GPs should use such surplus vaccines in the following manner so as to ensure no vaccines are wasted. * In order to honour the intention of the NIAC vaccination recommendations that those at highest risk of severe disease and death be vaccinated first, it is recommended that remaining doses of vaccine be given to people in allocation group 4 (that is those people with medical conditions that places them at very high risk of severe disease). In so far as possible, priority within this group should be given to those aged 65 to 69 given the importance of age as a risk factor for severe disease. * In the event that patients from allocation group 4 are not available for vaccination for any reason, vaccine should be administered to patients in the next allocation groups for vaccination. As it is planned that allocation groups 5 and 6 will be vaccinated in mass vaccination centres and allocation group 7 will be vaccinated in General Practice, it is pragmatic for GPs to vaccinate people from their allocation group 7 list if no one from allocation group 4 is available for vaccination within the time frame for use of the vaccine. * You will be given sufficient vaccine to administer 2nd Doses to those on your contingency list as above Allocation group 3 is those aged 70 years and older Allocation group 4 is those with medical conditions that place them at very high risk of severe disease in the 16-69 age group Allocation group 5 is those with medical conditions that place them at high risk of severe disease in the 65-69 age group Allocation group 6 is all other people in the 65-69 age group Allocation group 7 is people with medical conditions that place them at high risk of severe disease in the 16-64 age group Please note further guidance will issue in respect of the use of surplus vaccines on the final (Dose 2) clinics as the MRNA programme in General Practice closes out. Yours sincerely, IMO Team This email was sent to gavin.maguire@centrichealth.ie<mailto:gavin.maguire@centrichealth.ie> from imo@imo.ie Unsubscribe<http://imo.newsweaver.com/memberadvisory/unsubscribe/unsubscribe.html?s=fyod79xdkvj&m=001xsh91n4v9o8qsfjq2uu&email=true&lang=en> | Receive in Plain Text<http://imo.newsweaver.com/memberadvisory/subscriber/switchFormat.html?subscriberId=fyod79xdkvj&mailingRecordId=001xsh91n4v9o8qsfjq2uu&to=TEXT&email=true&lang=en> | Report Misuse<http://imo.newsweaver.com/memberadvisory/1v12ckf67spfyod79xdkvj/abuse.html> This e-mail and any attachments including voice attachments may contain confidential, personal, sensitive, proprietary or legally privileged information. Anyone who is not the intended recipient should not use or open the document. Any information or voice recording used within this document or e-mail should not be forwarded to any other legal person or organisation or posted on any social media platform as to do so would be in breach of privacy and data protection legislation. If you have erroneously received this email or document, please delete immediately and notify the sender. If you have received this e-mail or documentation where there is a precise reason to forward to a third party, all rules regarding privacy and data protection should be followed. You will be liable for a third party breach.The recipients acknowledge that Centric Health or associated companies are unable to exercise control to ensure or guarantee the integrity of/over the contents of the information contained in e-mail transmission and further acknowledge that any views expressed in this message are those of the individual sender and no binding nature of the message shall be implied or assumed unless the sender does so expressly with due authority of Centric Health.